XERIS BIOPHARMA HOLDINGS, INC. Earnings Per Share, Basic and Diluted
XERIS BIOPHARMA HOLDINGS, INC. (XERS) reported Earnings Per Share, Basic and Diluted of -$1.55 per share for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-11.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2022-03-11
- XERIS BIOPHARMA HOLDINGS, INC. earnings per share, basic and diluted for the quarter ending 2021-09-30 was -$0.39.
- XERIS BIOPHARMA HOLDINGS, INC. earnings per share, basic and diluted for the quarter ending 2020-09-30 was -$0.35.
- XERIS BIOPHARMA HOLDINGS, INC. earnings per share, basic and diluted for fiscal 2021 was -$1.55.
- XERIS BIOPHARMA HOLDINGS, INC. earnings per share, basic and diluted for fiscal 2020 was -$2.14.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 12 month |
|---|---|---|---|
| 2021-12-31 | -$1.55 10-K · filed 2022-03-11 | ||
| 2021-09-30 | -$0.39 10-Q · filed 2021-11-10 | -$1.11 10-Q · filed 2021-11-10 | |
| 2020-12-31 | -$2.14 10-K · filed 2022-03-11 | ||
| 2020-09-30 | -$0.35 10-Q · filed 2021-11-10 | -$1.78 10-Q · filed 2021-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Innoviva, Inc. (INVA) | United States | $1.493B | 4.62 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |